Clinical trial
Treatment of Episodic Migraine With AURICular Neuromodulation: a Prospective Randomized, Placebo-controlled Study
NCT06623188 is registered in ClinicalTrials.gov with Hôpital Européen Marseille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Episodic Migraine With AURICular Neuromodulation: a Prospective Randomized, Placebo-controlled Study
- Lead sponsor
- Hôpital Européen Marseille
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 20, 2025
- Completion date
- November 20, 2027
- Enrollment
- 106 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.